-

Featured
Many Brain Tumors May Yield to AI Algorithms
Meningiomas account for about 40% of all central nervous system tumors. A relatively new classification system can help focus clinicians’ attention on the best treatment approach. By John Halamka, M.D., M.S., Dwight and Dian Diercks President, Mayo Clinic Platform and Paul Cerrato, MA, senior research analyst and communications specialist, Mayo Clinic Platform While most patients…
By John Halamka and Paul Cerrato — In this new series, we pull back the curtain on the Wizard of Oz to provide plain English explanations about machine learning, artificial neural networks, natural language processing, large language models, and related technology.
By John Halamka and Paul Cerrato — Given their tendency to invent “facts,” several researchers have begun comparing their strengths and weaknesses.
By John Halamka and Paul Cerrato—A well-reasoned, coherent thesis is not enough to convince editorial gatekeepers to accept your article. Consider these additional suggestions.
Mayo Clinic's Cancer CARE Beyond Walls program, launched in 2023, has provided over 200 chemotherapy treatments at home and plans to expand, offering clinical trials and virtual nurse support for patients in Florida while aiming to bring the service to additional locations.
By John Halamka and Paul Cerrato — Mayo Clinic’s Tapestry Study has demonstrated that next generation genetic analysis can have a significant impact on patient care.
Against the backdrop of the 43rd Annual J.P. Morgan Healthcare Conference, Mayo Clinic announced the formation of Mayo Clinic Digital Pathology, designed on a platform architecture to boldly unlock the power of its extensive archive of digital slides to revolutionize pathology and accelerate medical breakthroughs.
By John Halamka and Paul Cerrato — Imagine if you could create a digital clone of yourself that can be used to test various treatment options to determine which one is best for your real self.
By John Halamka and Paul Cerrato — Data scientists use a variety of coding languages to create AI-driven models, but the real “secret sauce” that helps them identify the best algorithms are the weights the coding generates.
By John Halamka and Paul Cerrato — Several of these digital tools are supported by strong evidence and are worth considering, not to replace your clinical judgement, but to augment it.
By John Halamka and Paul Cerrato — All the good things in the world worth believing, and among those good things are the therapeutic power of kindness and the healing effects of music.
By John Halamka, Paul Cerrato, and Sonya Makhni — How do you construct a safe, effective algorithm? It’s not an easy question to answer, but with a well thought out roadmap, it’s doable.
Mayo Clinic Platform_Accelerate has announced a strategic agreement with the Japan External Trade Organization (JETRO) to implement a two-phase program aimed at enhancing U.S. healthcare and business immersion opportunities for Japanese health technology companies.